By spending just Rs 6,000 crore, the government can make a huge dent in the treatment of all sick people across the whole country — currently, people are spending as much as Rs 25,000 crore on buying essential medicines. This was the strong message sent out from a National Consultation organized by several civil society groups at New Delhi on Tuesday. Officials of the health ministry and the Planning Commission...

In April last year, the Supreme Court, in response to a public interest litigation filed by the Gene Campaign (whose convenor is the internationally known geneticist Dr Suman Sahai), directed the Genetic Engineering Approval Committee (GEAC) to consider the toxicity and allergenicity of GM crops and to post the relevant material on the web so that independent experts could examine these. The Supreme Court asked the GEAC to study also...

India has played a crucial role in making essential medicines available and affordable for patients in the developing world through generic drugs. This has been possible by linking India’s patent policies and laws to public interest. Similarly, policies that align public funded R&D in India with public health have the potential to provide incentives to the development of medical technologies (vaccines, diagnostics and medicines) crucial for treating neglected diseases like...

The health ministry has placed an order to import 1.5 million doses of the swine flu vaccine into India, which will be available in January. This is contrary to the government’s earlier claims of importing four million doses of the vaccine. Indian manufacturers will now supply the remaining doses. “We have placed an order for importing 1.5 million doses already,” said Vineet Chawdhry, joint secretary, health ministry. “Indigenous production of...

The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated...